Department of Chemestry
Short biography and Publications by Kerstin A. David
Short biographie
| 1960 | born in Hamburg |
| 1996 | Promotion with Carl-Wilhelm Vogel in Hamburg |
| 1997-1999 | Research Assistant (C1), Department of Chemistry, University of Hamburg, Department of Biochemistry and Molecular Biology |
| 1999-2001 | Assistant Professor, Cancer Research Center of Hawaii, University of Hawaii. in Manoa, USA |
| 2001-2003 | Research group leader (C1), Department of Chemistry, University of Hamburg, Department of Biochemistry and Molecular Biology |
| 2002 | Habilitation in Hamburg |
| 2002- | Head of Laboratory, Research and Services (Vice President Research & Services) of Indivumed GmbH, Hamburg |
| 2003- | Private lecturer in biochemistry and molecular biology at the University of Hamburg |
Further Information
Publications
| Search: Chemistry Dep. / all Hamburg | |
| 2008 | |
| 24 |
Sample preparation by laser microdissection and catapulting for proteome analysis Karin Schütze, Andrea Buchstaller, Yilmaz Niyaz, Christian Melle, Günther Ernst, Kerstin A. David, Thorsten Schlomm, Ferdinand von Eggeling -/- Editors: Jörg von Hagen Proteomics Sample Preparation 219-234 (2008), ISBN 978-3-527-31796-7 |
2007 | |
| 23 |
Detection of colorectal adenoma and cancer based on transthyretin and C3a-desArg serum levels Anne-Kristin Fentz, Monika Spörl, Jörg Spangenberg, Heinz Joachim List, Carsten Zornig, Arnulf Dörner, Peter Layer, Hartmut Juhl, Kerstin A. David Proteomics: Clinical Applications 1, 536-544 (2007) |
| 22 |
Use of endoplasmin fragment as a biomarker for colorectal adenoma and/or carcinoma Hartmut Juhl, Kerstin A. David, Anne-Kristin Fentz -/- Applicant: Indivumed GmbH Patent: WO 2007019875 (A1) 2007-02-22 |
| 21 |
Use of c3a and derivatives thereof as a biomarker for benign lung tissue alterations and malignant lung tumors, method for detection and test system Hartmut Juhl, Kerstin A. David -/- Applicant: Indivumed GmbH Patent: WO 2007065463 (A1) 2007-06-14 |
2006 | |
| 20 |
Use of transthyretin as a biomarker for colorectal adenoma and/or carcinoma; method for detection and test system Hartmut Juhl, Kerstin A. David -/- Applicant: Indivumed GmbH Patent: WO 2006015616 (A1) 2006-02-16 |
| 19 |
Use of c3a and derivatives thereof as a biomarker for colorectal ademona and/or carcinoma; diagnosis method and test system using the same Hartmut Juhl, Kerstin A. David, Anne-Kristin Fentz -/- Applicant: Indivumed GmbH Patent: WO 2006053592 (A1) 2006-05-26 |
2005 | |
| 18 |
Extraction and processing of high quality RNA from impalpable and macroscopically invisible prostate cancer for microarray gene expression analysis Thorsten Schlomm, Andreas M. Luebke, Holger Sültmann, Olaf J. C. Hellwinkel, Ulrich Sauer, Annemarie Poustka, Kerstin A. David, Felix K.-H. Chun , Alexander Haese, Markus Graefen, Andreas Erbersdobler, Hartwig Huland International Journal of Oncology 27, 713-720 (2005) |
| 17 |
Detection and quantification of mutations in the plasma of patients with colorectal tumors Frank Diehl, Meng Li, Devin Dressman, Yiping He, Dong Shen, Steve Szabo, Luis A. Diaz, Steven N. Goodman, Kerstin A. David, Hartmut Juhl, Kenneth W. Kinzler, Bert Vogelstein Proceedings of the National Academy of Sciences of the United States of America 102, 16368-16373 (2005) |
2004 | |
| 16 |
Tissue
ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision Annika Sprüssel, Garnet Steimann, Mira Jung, Sung A. Lee, Theresa Carr, Anne-Kristin Fentz, Jörg Spangenberg, Carsten Zornig, Hartmut Juhl, Kerstin A. David BioTechniques 36, 1030-1037 (2004) |
2002 | |
| 15 |
Key role of mitochondria in cerulenin-mediated apoptosis Sven Heiligtag, Reinhard Bredehorst, Kerstin A. David Cell Death and Differentiation 9, 1017-1025 (2002) |
| 14 |
Identifizierung und Charakterisierung von Apoptose-induzierenden Wirkstoffen zur Behandlung des Neuroblastom Kerstin A. David Habilitationsschrift, Hamburg (2002) |
2001 | |
| 13 |
A novel metastatic animal model reflecting the clinical appearance of human neuroblastoma: growth arrest of orthotopic tumors by natural, cytotoxic human immunoglobulin M antibodies Sylvia Engler, Christian Thiel, Kristine Förster, Kerstin A. David, Reinhard Bredehorst, Hartmut Juhl Cancer Research 61, 2968-2973 (2001) |
| 12 |
What establishes a protein as an allergen? Reinhard Bredehorst, Kerstin A. David Journal of Chromatography, B 756, 33-40 (2001) |
| 11 |
Initial characterization of the apoptosis-inducing receptor for natural human anti-neuroblastoma IgM Kerstin A. David, Sven Heiligtag, Markus W. Ollert , M. Teppke, Carl-Wilhelm Vogel, Reinhard Bredehorst Medical and Pediatric Oncology 36, 251-257 (2001) |
1999 | |
| 10 |
Human natural immunoglobulin M antibodies induce apoptosis of human neuroblastoma cells by binding to a Mr 260,000 antigen Kerstin A. David, Markus W. Ollert , Caren Vollmert, Sven Heiligtag, Britta Eickhoff, Rudolf Erttmann, Reinhard Bredehorst, Carl-Wilhelm Vogel Cancer Research 59, 3768-3775 (1999) |
| 9 |
Natural human IgM-antibodies in neuroblastoma therapy: preliminary findings of a phase I/II clinical trial Caroline Schmitt, Kerstin A. David, J. Hiller, J. Schrum, Reinhard Bredehorst, Carl-Wilhelm Vogel, C. Löliger, Rudolf Erttmann Klinische Pädiatrie 211, 314-318 (1999) |
1997 | |
| 8 |
Expression of a 260 kDa neuroblastoma surface antigen, the target of cytotoxic natural human IgM: correlation to MYCN amplification and effects of retinoic acid Kerstin A. David, A. Ehrhardt, Markus W. Ollert , Rudolf Erttmann, Reinhard Bredehorst, Carl-Wilhelm Vogel European Journal of Cancer 33, 1937-1941 (1997) |
| 7 |
Mechanisms of in vivo antineuroblastoma activity of human natural IgM Markus W. Ollert , Kerstin A. David, Caren Vollmert, Hartmut Juhl, Rudolf Erttmann, Reinhard Bredehorst, Carl-Wilhelm Vogel European Journal of Cancer 33, 1942-1948 (1997) |
1996 | |
| 6 |
Growth arrest of solid human neuroblastoma xenografts in nude rats by natural IgM from healthy humans Kerstin A. David, Markus W. Ollert , Hartmut Juhl, Caren Vollmert, Rudolf Erttmann, Carl-Wilhelm Vogel, Reinhard Bredehorst Nature Medicine 2, 686-689 (1996) |
| 5 |
Naturally occurring humoral cytotoxicity against neuroblastoma (NB) cells in healthy persons and NB patients Rudolf Erttmann, Caroline Schmitt, Markus W. Ollert , Kerstin A. David, Reinhard Bredehorst, Carl-Wilhelm Vogel Pediatric Hematology and Oncology 13, 545-548 (1996) |
| 4 |
Normal human serum contains a natural IgM antibody cytotoxic for human neuroblastoma cells Markus W. Ollert , Kerstin A. David, Caroline Schmitt, Alexander Hauenschild, Reinhard Bredehorst, Rudolf Erttmann, Carl-Wilhelm Vogel Proceedings of the National Academy of Sciences of the United States of America 93, 4498-4503 (1996) |
| 3 |
Natürliche zytotoxische Antikörper gegen humane Neuroblastom-Zellen. Analyse der zytotoxischen Mechanismen und Charakterisierung des Antigens Kerstin A. David (= Kerstin David) -/- Supervisor: Carl-Wilhelm Vogel Dissertation, Hamburg (1996), ISBN 978-3-928943-89-5; 3-928943-89-8 , Publisher: Wissenschaft und Technik Verl. Groß, Berlin |
1995 | |
| 2 |
Classical complement pathway activation on nucleated cells. Role of factor H in the control of deposited C3b Markus W. Ollert , Kerstin A. David, Reinhard Bredehorst, Carl-Wilhelm Vogel Journal of Immunology 155, 4955-4962 (1995) |
1994 | |
| 1 |
Antibody-mediated complement activation on nucleated cells Markus W. Ollert , Joseph V. Kadlec, Kerstin A. David, Eugene C. Petrella, Reinhard Bredehorst, Carl-Wilhelm Vogel Journal of Immunology 153, 2213-2221 (1994) |